Patents/Assignees

Hangzhou Solipharma Co., Ltd.

3 patents in portfolio

US12103925utility2024
Crystal and Amorphous Form of Tolebrutinib, Preparation Method Therefor, and Use Thereof
0 cites
US11919906utility2024
Crystal Form of ACP-196 and Method of Treatment Thereof
0 cites
US11639341utility2023
Crystal Form of Tipifarnib and Method of Treatment Thereof
0 cites